FIELD: medicine, gerontology. SUBSTANCE: method involves the use deuterium oxide (D2O) - heavy isotope of water in order to replace water part in organism as an agent for prophylaxis, supporting and recovering therapy. EFFECT: enhanced effectiveness of agent proposed. 8 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR CONSERVATION OF GRANULAR FISH CAVIAR | 1996 |
|
RU2098975C1 |
| AGENT FOR TREATMENT AND PROPHYLAXIS OF DISEASE AND STATE ACCOMPANYING WITH VOMITING, DIARRHEA AND INTOXICATION | 1994 |
|
RU2071769C1 |
| APPLICATION OF LITHIUM ASCORBATE FOR PREVENTION AND TREATMENT OF CHRONIC ALCOHOLIC INTOXICATION | 2017 |
|
RU2639496C1 |
| METHOD OF INVESTIGATION OF PROPERTIES OF HEAT SHOCK PROTEIN (HSP70) | 2007 |
|
RU2334988C1 |
| METHOD OF TREATING CRANIOCEREBRAL INJURY AND AGENT FOR IMPLEMENTATION THEREOF | 2023 |
|
RU2826364C1 |
| INTERLEUKIN-10, USING IT AND BASED COMPOSITION FOR TREATING BRAIN NEURODEGENERATIVE PROCESSES | 2012 |
|
RU2538613C2 |
| AGENT HAVING A PROPERTY TO PREVENT DEATH OF GABA-ERGIC NEURONS IN CONDITIONS OF ACUTE PERINATAL HYPOXIA | 2017 |
|
RU2672918C1 |
| NMDA RECEPTOR MODULATORS AND USING THEM | 2009 |
|
RU2515615C2 |
| METHOD OF ASSESSING THE TOXIC EFFECT OF A BIMETALLIC FERRUM-GADOLINIUM NANOCOMPOSITE ENCAPSULATED IN A NATURAL POLYMER MATRIX OF ARABINOGALACTAN ON LABORATORY ANIMALS | 2019 |
|
RU2733504C1 |
| MEDICINE COMPOSITION, POSSESSING NOOTROPIC ACTIVITY | 2007 |
|
RU2331432C1 |
